HIGHLIGHTS
- who: Steffen, Fuchs and Julian, Naderi from the Berlin Institute of Health (BIH), Berlin, Germany have published the Article: Molecular Sciences, in the Journal: (JOURNAL)
SUMMARY
ALK-Positive Anaplastic Large Cell Lymphoma: Pathology and Clinical Features Anaplastic large cell lymphoma (ALCL) is a rare and aggressive peripheral T-cell non-Hodgkin lymphoma (NHL), belonging to the group of CD30-positive lymphoproliferative disorders. The 2016 WHO classification identifies four separate biological entities: primary systemic ALK-positive ALCL (ALK-positive ALCL), primary systemic ALK-negative ALCL, primary cutaneous ALCL and breast implant-associated ALCL. The . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.